Full Circle Consulting

EMMA International can be there every step of the way for your product! From product development to helping with QMS upkeep and post-market monitoring, EMMA is here to bring your product full-circle. The expertise of the EMMA team can help you get through the biggest quality and regulatory hurdles in the life science industry with ease.

Full Service

Full Circle Consulting

EMMA OnDemand


Quality System Development

Quality System Implementation

Post Market Compliance

ISO Standards Consulting


Product Development

Manufacturing & Distribution


Regulatory Strategy

Regulatory Submissions


Featured Services

Project Management

Staff Augmentation

Ready to learn more about working with us?

Full Circle Consulting Resources

Applying ISO 14971 to AI/ML

Applying ISO 14971 to AI/ML

Everyone is aware that ISO 14971 is the gold standard for risk management of medical devices. As the regulatory landscape evolves to forge a path for innovative technology like AI/ML devices, it begs the question of how to apply our existing systems and methodologies to novel technology that is inevitably the future of healthcare.
Understanding Biosimilar Products

Understanding Biosimilar Products

A Biosimilar is essentially a biologic product that is similar and has no clinically significant difference in terms of safety, purity, and potency from an existing approved Biologic on the market.
The FDA and AI/ML in Medical Devices: Navigating the Future of Healthcare

The FDA and AI/ML in Medical Devices: Navigating the Future of Healthcare

Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing healthcare, offering unprecedented opportunities to improve patient outcomes, streamline processes, and enhance diagnostic accuracy. As AI and ML continue to make significant strides in the medical field, the U.S. Food and Drug Administration (FDA) plays a pivotal role in regulating these innovations. In this blog post, we'll explore the intersection of AI/ML and medical devices, and how the FDA is navigating this rapidly evolving landscape.
The FDA’s Update to Biocompatibility Guidance

The FDA’s Update to Biocompatibility Guidance

The FDA’s guidance document on the use of ISO 10993-1 was updated this month with some crucial information for medical device manufacturers. Biocompatibility testing has been a long-standing requirement for a majority of device manufacturers, so this update that includes some excluded materials and devices is a welcome change.

Pin It on Pinterest